Sassi, Angelina
Lestari, Bony Wiem
El Muna, Kuuni Ulfah Naila
Oga-Omenka, Charity
Afifah, Nur
Widarna, Rodiah
Huria, Lavanya
Aguilera Vasquez, Nathaly
Benedetti, Andrea
Hadisoemarto, Panji Fortuna
Daniels, Benjamin
Das, Jishnu
Pai, Madhukar
Alisjahbana, Bachti
Funding for this research was provided by:
Bill and Melinda Gates Foundation (INV-022420, INV-022420, INV-022420, INV-022420, INV-022420, INV-022420, INV-022420, INV-022420, INV-022420, INV-022420, INV-022420, INV-022420, INV-022420, INV-022420)
University of Padjadjaran
Article History
Received: 3 July 2023
Accepted: 16 October 2023
First Online: 5 January 2024
Declarations
:
: This study was approved by the McGill University Health Centre (MUHC) Research Ethics Board (REB) (COVID BMGF / 2021-7197), Georgetown University (Georgetown-MedStar IRB System STUDY00003422), and the Research Ethics Committee of Universitas Padjadjaran, Bandung, Indonesia (No.166/UN6.KEP/EC/2021). All methods were carried out in accordance with relevant guidelines and regulations in the Declaration of Helsinki. Informed consent was waived by the MUHC REB to ensure that providers would undergo their normal routine, thus ensuring the validity of the data collected for this study.
: Not applicable.
: One author, MP, serves as an advisor and paid consultant to the World Health Organization, Stop TB Partnership, Bill & Melinda Gates Foundation, and Foundation for Innovative New Diagnostics. The other authors declare that they have no financial or industry-related conflicts.